01 1Curia
01 1FENTANYL
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-03-28
Pay. Date : 2013-03-20
DMF Number : 18194
Submission : 2005-03-23
Status : Active
Type : II
20
Siegfried Grafton Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is FENTANYL, with a corresponding US DMF Number 18194.
Remarkably, this DMF maintains an Active status since its submission on March 23, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 28, 2013, and payment made on March 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
